Table 1.

Clinical characteristics of 78 patients and the expression of miR-429 in CRC tissues.

Factors	Case	MiR-429 Median (range)	P
Gender			0.826
Male	49	4.81 (1.12–8.65)
Female	29	4.98 (1.24–7.87)
Age(years)			0.537
<60	43	4.64 (1.24–6.77)
≥60	35	4.99 (1.26–7.71)
Tumor size			0.036
<6 cm	49	3.89 (1.24–7.23)
≥6 cm	29	5.02 (2.26–8.98)
Tumor location			0.198
Colon	37	4.64 (1.45–7.46)
Rectum	41	5.05 (2.12–7.77)
Differentiation			0.218
Well	27	4.77 (1.45–6.65)
Moderate	33	4.56 (2.30–7.10)
Poor	18	5.32 (3.11–8.17)
Local invasion			0.063
T1–T2	27	4.38 (1.12–7.65)
T3–T4	51	4.99 (2.98–8.76)
Lymph node metastasis			0.001
No	42	3.36 (1.26–7.38)
Yes	36	5.71 (3.31–8.78)
Distant metastasis			0.000
No	71	3.56 (1.38–7.02)
Yes	7	5.56 (2.99–8.98)
TNM stage
I–II	42	3.32 (1.26–6.15)	0.000
III–IV	36	5.98 (2.78–8.43)